HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel R Salomon Selected Research

H-2 Antigens (H 2 Antigens)

1/2009Intragraft TNF receptor signaling contributes to activation of innate and adaptive immunity in a renal allograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel R Salomon Research Topics

Disease

4Infections
04/2012 - 11/2002
3Cystinosis
02/2013 - 09/2009
2Fibrosis (Cirrhosis)
01/2019 - 04/2013
2Neoplasms (Cancer)
11/2018 - 04/2016
1Atrophy
01/2019
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2018
1Leukemia
11/2018
1Hematologic Neoplasms (Hematological Malignancy)
11/2018
1T-Cell Leukemia (Leukemia, T Cell)
11/2018
1Genomic Instability
05/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017
1Pain (Aches)
03/2016
1Fibromyalgia (Fibrositis)
03/2016
1Polyneuropathies (Polyneuropathy)
01/2016
1Cardiomyopathies (Cardiomyopathy)
01/2016
1Amyloid Neuropathies (Amyloid Neuropathy)
01/2016
1Acute Kidney Injury (Acute Renal Failure)
12/2014
1Chronic Kidney Failure (Chronic Renal Failure)
02/2013
1Amyloidosis
06/2012
1Kidney Diseases (Kidney Disease)
06/2011
1Inflammation (Inflammations)
01/2009
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2006
1Pneumoperitoneum
10/2005
1Ischemia
10/2005
1von Willebrand Diseases (von Willebrand's Disease)
10/2004
1Hemorrhage
10/2004

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2014
1AntibodiesIBA
01/2019
1Sirolimus (Rapamycin)FDA Link
11/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2018
1RNA-Binding Proteins (RNA-Binding Protein)IBA
04/2016
1Estrogen ReceptorsIBA
04/2016
1RNA Splicing FactorsIBA
04/2016
1Glutamic Acid (Glutamate)FDA Link
03/2016
1Glutamine (L-Glutamine)FDA Link
03/2016
1tafamidisIBA
01/2016
1Amyloid (Amyloid Fibrils)IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1Pharmaceutical PreparationsIBA
04/2013
1Proteins (Proteins, Gene)FDA Link
02/2013
1enhanced green fluorescent proteinIBA
02/2013
1Cystine (L-Cystine)IBA
02/2013
1fluorescent protein 583IBA
02/2013
1Prealbumin (Transthyretin)IBA
06/2012
1Toll-Like Receptor 4IBA
04/2012
1Interferon-gamma (Interferon, gamma)IBA
01/2009
1CytokinesIBA
01/2009
1Transcription Factors (Transcription Factor)IBA
01/2009
1InterferonsIBA
01/2009
1InterleukinsIBA
01/2009
1ChemokinesIBA
01/2009
1E-SelectinIBA
01/2009
1Oncostatin M Receptors (Oncostatin M Receptor)IBA
01/2009
1Interferon Regulatory FactorsIBA
01/2009
1H-2 Antigens (H 2 Antigens)IBA
01/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2009
1erucylphosphocholineIBA
01/2006
1von Willebrand FactorIBA
10/2004
1Peptide Hydrolases (Proteases)FDA Link
11/2002
1Complement System Proteins (Complement)IBA
11/2002

Therapy/Procedure

5Therapeutics
11/2018 - 09/2009
3Transplantation
01/2017 - 09/2009
2Heterologous Transplantation (Xenotransplantation)
05/2003 - 11/2002
1Kidney Transplantation
12/2014
1Liver Transplantation
12/2014
1Stem Cell Transplantation
06/2011
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2009
1Mesenchymal Stem Cell Transplantation
09/2009
1Nephrectomy
10/2005